Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brachman, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brachman, P. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 155, No. 11 : 981-987
Copyright © 2002 by The Johns Hopkins University School of Hygiene and Public Health

INVITED COMMENTARY

Bioterrorism: An Update with a Focus on Anthrax

Philip S. Brachman

From the Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Room 742, Atlanta, GA 30322 (e-mail: pbrachm@sph.emory.edu).

Abbreviations: CDC, Centers for Disease Control and Prevention

The current problem with anthrax, a disease of antiquity with a reputation that has exceeded its actual impact on human health, has brought into reality the meaning of bioterrorism. No matter how prepared a population may be, bioterrorism cannot be prevented. The first case or cases will occur and will serve to alert the authorities to initiate the preexisting plan to limit the quantitation of the bioterrorist event.

Although much effort may have been expended in developing a response to a bioterroristic event, it is likely that deficiencies will become apparent as the plan is implemented, partly because some aspects of any plan will vary depending on the agent involved. This is portrayed by the current bioterroristic anthrax event. Although not the preferred method of testing a plan, lessons will be learned from the current activities, necessitating corrections and additions to the plans. This will strengthen our ability to respond . . . [Full Text of this Article]

FEATURES OF BIOTERRORISM

BIOTERRORISM RESPONSE

ANTHRAX

NOTES

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Appl. Environ. Microbiol.Home page
A. Kurth, J. Achenbach, L. Miller, I. M. Mackay, G. Pauli, and A. Nitsche
Orthopoxvirus Detection in Environmental Specimens during Suspected Bioterror Attacks: Inhibitory Influences of Common Household Products
Appl. Envir. Microbiol., January 1, 2008; 74(1): 32 - 37.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. N. Kyriacou, P. R. Yarnold, A. C. Stein, B. P. Schmitt, R. C. Soltysik, R. R. Nelson, R. R. Frerichs, G. A. Noskin, S. M. Belknap, and C. L. Bennett
Discriminating Inhalational Anthrax From Community-Acquired Pneumonia Using Chest Radiograph Findings and a Clinical Algorithm
Chest, February 1, 2007; 131(2): 489 - 496.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. EthicsHome page
M H Kottow
Should medical ethics justify violence?
J. Med. Ethics, August 1, 2006; 32(8): 464 - 467.
[Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Marcus, R. Danieli, E. Epstein, B. Velan, A. Shafferman, and S. Reuveny
Contribution of Immunological Memory to Protective Immunity Conferred by a Bacillus anthracis Protective Antigen-Based Vaccine
Infect. Immun., June 1, 2004; 72(6): 3471 - 3477.
[Abstract] [Full Text] [PDF]